In Silico and In Vitro Evaluation of Selected Herbal Compounds as Robust HER-2 Inhibitors for Effective Treatment of Breast Cancer

• Váldodahkkit: Mona Pourjafar (Dahkki), Naghmeh Shirafkan (Dahkki), Somaye Bakhtiari (Dahkki), Saeid Afshar (Dahkki), Massoud Saidijam (Dahkki), Alireza Jalalvand (Dahkki), Amir Taherkhani* (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Iranian Society of Pharmacognosy, 2023-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background and objectives: Breast cancer is the most frequently reported malignancy in women worldwide and is a heterogeneous disease. Due to different levels of human epidermal growth factor receptor 2 (HER-2) and its critical role in tumor progression, HER-2 has been considered as a validated targ...